Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Intrahepatic Peripheral Cholangiocarcinoma in Cirrhosis Patients May Display A Vascular Pattern Similar to Hepatocellular Carcinoma on Contrast-Enhanced Ultrasound
2010
A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis
2019 Standout
Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI
2012
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma
2014
Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States
2019
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON
2016
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
2018
Accepting clocks that tell time poorly: Fluid-phase versus standard ELISA autoantibody assays
2007
The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series
2014
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma
2011
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
2014
Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10–20 mm) detected in the cirrhotic liver at screening ultrasound
2017
Is tumor biopsy necessary?
2011
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
2017
Hepatocellular carcinoma
2012 Standout
A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis
2006
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2cm
2014
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging
2015
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria
2008
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma
2015
Liver Imaging Reporting and Data System v2014 With Gadoxetate Disodium–Enhanced Magnetic Resonance Imaging
2016
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
2018
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States
2009
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Electromagnetic-Tracked Biopsy under Ultrasound Guidance: Preliminary Results
2011
Non-alcoholic fatty liver disease
2021 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation
2010
Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
2010
Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
2015
Dynamic enhancing vascular pattern of intrahepatic peripheral cholangiocarcinoma on contrast-enhanced ultrasound: the influence of chronic hepatitis and cirrhosis
2012
The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE
2013
Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US
2015
Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review. CME
2006
MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies
2008
Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features
2017
Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis
2015
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
2007
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
2017
Glypican-3 Expression Distinguishes Small Hepatocellular Carcinomas From Cirrhosis, Dysplastic Nodules, and Focal Nodular Hyperplasia-like Nodules
2006
Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma
2008
Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI
2015
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
2009
How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma
2014
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
2015
Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none?
2010
Contrast-enhanced ultrasonography parameters in neural network diagnosis of liver tumors
2012
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
2013
Hepatocellular Carcinoma
2011 Standout
Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: Intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines
2011
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging–based Diagnosis of Hepatocellular Carcinoma: A Systematic Review
2017
Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Differentiating Small Hepatocellular Carcinomas (≤2 cm in Diameter) From Arterial Enhancing Pseudolesions
2010
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver
2007
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatocellular carcinoma
2022 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach
2015
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
2020
LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
2014
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
2017
APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review
2011
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Elastography for the differentiation of benign and malignant liver lesions: a meta-analysis
2014
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
2017
Impact of gadoxetic acid (Gd‐EOB ‐DTPA )‐enhanced magnetic resonance on the non‐invasive diagnosis of small hepatocellular carcinoma: a prospective study
2012
Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid‐enhanced MRI : comparison with multiphasic MDCT
2014
Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016
2017
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Boldine and its antioxidant or health-promoting properties
2005
Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: Role of biopsy
2011
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Works of Simona Leoni being referenced
Antibodies to soluble liver antigen and α-enolase in patients with autoimmune hepatitis
2004
Caution in the use of boldo in herbal laxatives: A case of hepatotoxicity
2005
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
2012
Characterization of Small Nodules in Cirrhosis by Assessment of Vascularity: The Problem of Hypovascular Hepatocellular Carcinoma *
2005
Characterization of liver lesions by real-time contrast-enhanced ultrasonography
2007
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group
2014
A New Priority Policy for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation Within the Model for End-Stage Liver Disease System
2007
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
2018
The Impact of Vascular and Nonvascular Findings on the Noninvasive Diagnosis of Small Hepatocellular Carcinoma Based on the EASL and AASLD Criteria
2009
Characterization of Primary and Recurrent Nodules in Liver Cirrhosis Using Contrast-Enhanced Ultrasound: Which Vascular Criteria Should Be Adopted?
2013
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound
2013